We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.61B
1-Year Est. Return 28.28%
This Fund
S&P 500
This Quarter Est. Return
-17.67%
1 Year Est. Return
+28.28%
3 Year Est. Return
+64.67%
5 Year Est. Return
+51.31%
10 Year Est. Return
+329.48%
AUM
$666M
AUM Growth
-$78.6M
Cap. Flow
+$47.8M
Cap. Flow %
7.17%
Top 10 Hldgs %
3.73%
Holding
1,985
New
628
Increased
360
Reduced
345
Closed
644

Top Buys

Rank Stock Value
1
RLAY icon
Relay Therapeutics
RLAY
+$3.83M
2
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$3M
3
TECK icon
Teck Resources
TECK
+$2.87M
4
MODV
ModivCare
MODV
+$2.67M
5
G icon
Genpact
G
+$2.6M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$3.07M
2
CHS
Chicos FAS, Inc.
CHS
+$2.68M
3
KRE icon
State Street SPDR S&P Regional Banking ETF
KRE
+$2.45M
4
CXT icon
Crane NXT
CXT
+$2.44M
5
ATCO
Atlas Corp.
ATCO
+$2.27M

Sector Composition

Rank Sector Weight
1 Healthcare 18.12%
2 Technology 15.11%
3 Consumer Discretionary 12.76%
4 Industrials 12.53%
5 Financials 11.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSX icon
76
Phillips 66
PSX
$82.5B
$1.22M 0.18%
+14,919
New +$1.38M
NE icon
77
Noble Corp
NE
$6.52B
$1.22M 0.18%
+47,952
New +$1.58M
HIG icon
78
Hartford Financial Services
HIG
$38.9B
$1.21M 0.18%
18,482
+6,776
+58% +$475K
WMK icon
79
Weis Markets
WMK
$1.94B
$1.21M 0.18%
16,204
-516
-3% -$40K
INGR icon
80
Ingredion
INGR
$6.6B
$1.21M 0.18%
+13,694
New +$1.23M
TKR icon
81
Timken Company
TKR
$9.18B
$1.21M 0.18%
+22,707
New +$1.33M
VRNT
82
DELISTED
Verint Systems
VRNT
$1.2M 0.18%
+28,415
New +$1.42M
PFGC icon
83
Performance Food Group
PFGC
$17.7B
$1.2M 0.18%
+26,141
New +$1.21M
MUSA icon
84
Murphy USA
MUSA
$10.9B
$1.2M 0.18%
+5,130
New +$1.21M
EXEL icon
85
Exelixis
EXEL
$14.1B
$1.19M 0.18%
56,974
+47,337
+491% +$976K
VRNS icon
86
Varonis Systems
VRNS
$4.98B
$1.19M 0.18%
40,450
+36,181
+848% +$1.34M
FAST icon
87
Fastenal
FAST
$57B
$1.18M 0.18%
+47,428
New +$1.28M
RAD
88
DELISTED
Rite Aid Corporation
RAD
$1.18M 0.18%
174,973
+56,309
+47% +$373K
MDT icon
89
Medtronic
MDT
$110B
$1.18M 0.18%
+13,108
New +$1.33M
DEI icon
90
Douglas Emmett
DEI
$2B
$1.17M 0.18%
52,367
+26,767
+105% +$746K
DK icon
91
Delek US
DK
$4.06B
$1.17M 0.18%
+45,345
New +$1.22M
PK icon
92
Park Hotels & Resorts
PK
$3.02B
$1.17M 0.18%
+86,202
New +$1.52M
MTRX icon
93
Matrix Service
MTRX
$343M
$1.17M 0.18%
230,597
-6,638
-3% -$41.6K
CALM icon
94
Cal-Maine
CALM
$3.98B
$1.17M 0.17%
23,571
+18,708
+385% +$949K
TCRT icon
95
Alaunos Therapeutics
TCRT
$4.64M
$1.17M 0.17%
6,261
+4,711
+304% +$450K
TRUP icon
96
Trupanion
TRUP
$1.08B
$1.16M 0.17%
19,275
+15,622
+428% +$1.06M
YOU icon
97
Clear Secure
YOU
$5.62B
$1.14M 0.17%
+57,136
New +$1.54M
STRO icon
98
Sutro Biopharma
STRO
$425M
$1.14M 0.17%
21,812
+18,268
+515% +$1.02M
X
99
DELISTED
US Steel
X
$1.14M 0.17%
+63,441
New +$1.73M
AXP icon
100
American Express
AXP
$234B
$1.13M 0.17%
+8,128
New +$1.34M
2 3
4
5 6

Similar funds

ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
SCI
S&CO Inc Boston, Massachusetts $1.61B AUM 21.39% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return
BW
Browning West Los Angeles, California $1.62B AUM 22.28% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.62B AUM 5.91% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PRA
Pine Ridge Advisers New York $1.62B AUM 16.97% 1-Year Est. Return
CC
Covalis Capital London, United Kingdom $1.63B AUM 27.84% 1-Year Est. Return

GSA Capital Partners's Q2 2022 Portfolio in Review

As of Q2 2022, GSA Capital Partners held 1,985 positions worth $666M, down 11% from $745M the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.

GSA Capital Partners deployed $47.8M of net new capital in Q2 2022, opening 628 new positions and adding to 360 existing holdings. Its largest new stake was Relay Therapeutics: 178,593 shares worth $2.99M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Chicos FAS, Inc., an estimated $2.68M trimmed.

  • GSA Capital Partners's largest Q2 2022 buy was Relay Therapeutics: 178,593 shares worth $2.99M.
  • GSA Capital Partners added most to Genpact in Q2 2022, an estimated $2.6M increase.
  • GSA Capital Partners's biggest Q2 2022 reduction was Chicos FAS, Inc., cutting an estimated $2.68M.
  • GSA Capital Partners fully exited Amazon in Q2 2022, selling an estimated $3.07M.
  • GSA Capital Partners's ten largest holdings make up 3.7% of its $666M portfolio in Q2 2022.
  • GSA Capital Partners opened 628 new positions and closed 644 in Q2 2022.
  • GSA Capital Partners's portfolio value fell 11% quarter-over-quarter to $666M.

Based on GSA Capital Partners's 13F filing for Q2 2022, filed 9 Aug 2022.